MRNA Moderna, Inc. stock chart & analysis
Conviction 0HealthcareScan · Fri, Nov 6, 2026Moderna, Inc. (MRNA) closed at $254.19 (+5.27%) on Nov 6, 2026. Its latest daily candle is a bullish harami. Price is above its 50-day and above its 200-day moving average. RSI(14) 64, RS Rating 99, -5.0% from its 52-week high, +761.8% year to date. Sector: Healthcare · Biological Products, (No Diagnostic Substances).
Why MRNA moved
From the StockSetups movers recaps that covered MRNA, newest first. A recap states what was known that day.
- Close+177.4%
According to headlines from Yahoo Finance and Stocktwits, Moderna's Phase 3 clinical trial for its melanoma therapy met its primary goal, triggering what was described as the stock's best-ever single day. Multiple outlets reported shares surging more than 60% premarket and continuing higher into the close.
Top Stock Movers Today — August 19, 2026: Why MRNA, CYPH, PURR, HUMA & MRVI Surged → - Premarket+88.2%
Moderna is having what multiple outlets are calling its best single day ever, surging +88.2% to $118.50 in premarket trading on 19.1 million shares — more than 3.5× its 20-day average of 5.3 million. This is one of the most significant single-session moves for a large-cap biotech in recent memory.
Premarket Stock Movers — August 19, 2026: Why YJ, MRNA, MRNY, EHGO & BIVI Are Surging →
Financials as of Wed, Sep 30, 2026 · quarterly.
MRNA technical analysis
Trend
MRNA is in an uptrend: price is above the 50-day, which is above the 200-day moving average. It closed 32.5% above the 50-day ($191.85) and 177.9% above the 200-day ($91.47). ADX(14) at 38 points to a strong, established trend. It meets 8 of 8 trend-template criteria.
Momentum
RSI(14) is 64, in the bullish half of its range. MACD crossed above its signal line 2 sessions ago. A bearish RSI divergence is in place. Its RS Rating of 99 puts its weighted 12-month performance ahead of about 99% of the US market, and its RS line is at a new high.
Volume and volatility
Volume on the latest session ran 0.9× its 20-day average. It trades about $3.7B a day on average. ATR(14) is $20.85, 8.2% of price — its typical daily range. Chaikin Money Flow (0.20) shows accumulation.
Key levels
The 52-week range is $22.28 to $267.42; price is 5.0% below the high and 1040.7% above the low. The VWAP anchored at the 52-week high is $253.25, below price.
Performance
MRNA returned +14.6% (1 week), +29.0% (1 month), +324.9% (3 months), +367.6% (6 months), +978.7% (1 year), +761.8% (year to date).
About Moderna, Inc.
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 35 mRNA development candidates in clinical studies as of August 2025. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
Biological Products, (No Diagnostic Substances) · Listed 2018 · 4,700 employees
Recent news
- Moderna, Inc.: Earnings resultsSEC EDGAR · Fri, Nov 6, 2026
- Moderna reported financial results and business updates: Will MRNA hold the MA-20?Traders Union · Fri, Nov 6, 2026
- Moderna: Q3 Earnings SnapshotYahoo Finance · Fri, Nov 6, 2026
- Moderna swings to profit as momentum for cancer vaccine buildsYahoo Finance · Fri, Nov 6, 2026
- Moderna Reports Third Quarter 2026 Financial Results and Provides Business UpdatesYahoo Finance · Fri, Nov 6, 2026
- Moderna reported $162 million in profit after a $200 million year-earlier loss.Stock Titan · Fri, Nov 6, 2026
- MRNA Stock Jumped 13% in a Single Day — Here’s the Story Behind the MoveFinancial-News.co.uk · Fri, Nov 6, 2026
- Invesco S&P 500 Equal Weight (RSP) Adds Okta and Moderna on Nov. 4Yahoo Finance · Fri, Nov 6, 2026
- 5,060 Moderna, Inc. $MRNA Shares Purchased by Rakuten Investment Management Inc.MarketBeat · Fri, Nov 6, 2026
- 6,541 Shares of Moderna, Inc. $MRNA Purchased by Caldwell Trust CoMarketBeat · Fri, Nov 6, 2026
Congress activity
Disclosed STOCK Act trades in MRNA · 5 recent
| Member | Side | Amount | Traded | Filed | PTR |
|---|---|---|---|---|---|
 Maria Elvira Salazar house · R · FL · traded 2026-09-24 | Sell | $1K–$15K | 2026-09-24 | 2026-10-07 | |
Maria Elvira Salazar house · R · FL · traded 2026-08-19 | Sell | $1K–$15K | 2026-08-19 | 2026-09-09 | |
 Rob Bresnahan house · PA · traded 2025-04-08 | Sell | $1K–$15K | 2025-04-08 | 2025-05-08 | |
Rob Bresnahan house · PA · traded 2025-02-25 | Buy | $1K–$15K | 2025-02-25 | 2025-03-27 | |
 Julie Johnson house · D · TX · traded 2025-01-15 | Sell | $1K–$15K | 2025-01-15 | 2025-02-12 |
Insider activity
SEC Form 4 transactions in MRNA
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Mock James M Chief Financial Officer · Common Stock · 2026-10-05 | Exercise | 1.45K | — | 2026-10-05 | 2026-10-07 |
Mock James M Chief Financial Officer · Common Stock · 2026-10-05 | Tax | 704 | $134K | 2026-10-05 | 2026-10-07 |
Mock James M Chief Financial Officer · Restricted Stock Units · 2026-10-05 | Exercise | 1.45K | — | 2026-10-05 | 2026-10-07 |
Mock James M Chief Financial Officer · Common Stock · 2026-08-28 | Tax | 160 | $23K | 2026-08-28 | 2026-08-31 |
Hoge Stephen President · Common Stock · 2026-08-28 | Exercise | 611 | — | 2026-08-28 | 2026-08-31 |
Hoge Stephen President · Common Stock · 2026-08-28 | Tax | 296 | $42K | 2026-08-28 | 2026-08-31 |
Hoge Stephen President · Restricted Stock Units · 2026-08-28 | Exercise | 611 | — | 2026-08-28 | 2026-08-31 |
Klinger Shannon Thyme Chief Legal Officer · Common Stock · 2026-08-28 | Exercise | 329 | — | 2026-08-28 | 2026-08-31 |
Klinger Shannon Thyme Chief Legal Officer · Common Stock · 2026-08-28 | Tax | 160 | $23K | 2026-08-28 | 2026-08-31 |
Klinger Shannon Thyme Chief Legal Officer · Restricted Stock Units · 2026-08-28 | Exercise | 329 | — | 2026-08-28 | 2026-08-31 |
SEC filings
EDGAR filings in MRNA · 10 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, no credit card.
Start free — 7-day trial, no card →Free daily signals by email. Top 3 setups per lane after every close. No account needed.
Unsubscribe anytime · Privacy
Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.